Language Select
Varian Logo

Press Releases

August 08, 2017
Varian Medical Systems (NYSE: VAR) today announced the first cancer patient was treated using the company's HyperArc™ High Definition Radiotherapy (HDRT), a new type of radiosurgery treatment,... Read more
August 01, 2017
Varian Medical Systems (NYSE: VAR) has received orders to provide full suites of software for national proton therapy centers now being constructed in the Denmark and the U.K. Varian is currently... Read more
July 27, 2017
According to the National Institutes of Health, an estimated six million dogs and six million cats are diagnosed with cancer each year in the US. Up to now the access to advanced treatments for... Read more
July 26, 2017
Varian Medical Systems (NYSE: VAR) installed a Varian ProBeam® cyclotron at the Georgia Proton Treatment Center, LLC in Atlanta. The cyclotron is a core piece of equipment of the ProBeam proton... Read more
July 26, 2017
Varian Medical Systems (NYSE: VAR) today announced that the University Hospitals Leuven (UZ Leuven) in Belgium, have ordered the new Halcyon™ treatment system. Scheduled to be installed in... Read more
July 26, 2017
Varian Medical Systems (NYSE:VAR), the world's leading manufacturer of medical devices and software for treating and managing cancer, today announced its third-quarter fiscal 2017 operating... Read more
July 25, 2017
Varian Medical Systems (NYSE: VAR) today announced it will be showcasing its latest radiotherapy and radiosurgery technologies and software July 30 – August 3 in Denver at the 2017 American... Read more
July 18, 2017
Varian Medical Systems (NYSE: VAR) announced today that radiation oncology professionals using its Eclipse™ treatment planning software created the top scoring head and neck cancer treatment... Read more
July 11, 2017
A 68-year-old breast cancer patient has become the first person in the nation of Georgia to be treated using the Edge™ radiosurgery system from Varian Medical Systems (NYSE: VAR) in combination... Read more
June 29, 2017
Varian Medical Systems (NYSE: VAR) has received FDA 510(k) clearance for its Halcyon™ system, its new device for cancer treatment. Halcyon simplifies and enhances virtually every aspect of... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
[email protected]

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
[email protected]

Monica Prokocki
Director, Investor Relations
650.424.5184
[email protected]